American Renal Associates Holdings, Inc. Sample Contracts

American Renal Associates Holdings, Inc. – AMENDMENT NO. 2 TO CREDIT AGREEMENT (November 9th, 2012)

This AMENDMENT No. 2 dated as of August 27, 2012 (this “Amendment”), is entered into among AMERICAN RENAL HOLDINGS INTERMEDIATE COMPANY, LLC, a Delaware limited liability company (“Holdings”), AMERICAN RENAL HOLDINGS INC., a Delaware corporation (the “Borrower”), the Subsidiary Guarantors party hereto and BANK OF AMERICA, N.A., in its capacity as administrative agent for the Lenders (as hereinafter defined) (in such capacity, the “Administrative Agent”), and amends the Credit Agreement dated as of May 7, 2010 (as amended to the date hereof and as the same may be further amended, supplemented or otherwise modified from time to time, the “Credit Agreement”) entered into among Holdings, the Borrower, the institutions from time to time party thereto as Lenders (the “Lenders”), the Administrative Agent, and the other agents and arrangers party thereto. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement.

American Renal Associates Holdings, Inc. – FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (June 6th, 2012)

This FIRST AMENDMENT to Employment Agreement (the “Amendment”) is made and entered into as of this 15th day of May, 2012 (the “Effective Date”) by and among American Renal Management, LLC, a Delaware limited liability company (the “Company”), American Renal Holdings, Inc., a Delaware corporation (“ARH”), American Renal Associates Holdings, Inc., a Delaware corporation (“ARAH”), and Joseph A. Carlucci, a resident of the Commonwealth of Massachusetts (the “Executive”).

American Renal Associates Holdings, Inc. – AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (May 18th, 2012)

This AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (as amended from time to time, this “Agreement”) is dated as of June 28, 2010, and is entered into by and among C.P. Atlas Holdings, Inc., a Delaware corporation (“Holdings”), Centerbridge Capital Partners, L.P., a Delaware limited partnership (“Centerbridge”), Centerbridge Capital Partners SBS, L.P., a Delaware limited partnership (“Centerbridge SB S”), Centerbridge Capital Partners Strategic, L.P., a Delaware limited partnership (“Centerbridge Strategic” and, collectively with Centerbridge and Centerbridge SBS, the “Centerbridge Stockholders”), and the other holders of Shares (as defined herein) party hereto, including such other holders who become party hereto as a result of executing the Joinder Agreement substantially in the form attached as Annex A hereto (such other holders are the “Other Stockholders”, and, together with the Centerbridge Stockholders, are collectively referred to herein as the “Stockholders”). The Other Stockhold

American Renal Associates Holdings, Inc. – AMERICAN RENAL ASSOCIATES ANNOUNCES FOURTH QUARTER 2011 RESULTS (March 14th, 2012)

Beverly, Massachusetts (March 14, 2012) – American Renal Associates Holdings, Inc., and its subsidiary American Renal Holdings Inc. announced results today for the quarter ended December 31, 2011. Financial and operating highlights include:

American Renal Associates Holdings, Inc. – AMERICAN RENAL ASSOCIATES ANNOUNCES THIRD QUARTER 2011 RESULTS (November 10th, 2011)

Beverly, Massachusetts (November 9, 2011) – American Renal Associates Holdings, Inc., and its subsidiary American Renal Holdings Inc. announced results today for the quarter ended September 30, 2011. Financial and operating highlights include:

American Renal Associates Holdings, Inc. – EMPLOYMENT AGREEMENT (October 14th, 2011)

This EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 13, 2011 (the “Effective Date”), among American Renal Management LLC, a Delaware limited liability company (the “Company”), American Renal Holdings Inc., a Delaware corporation (“ARH”), and Jonathan Wilcox, a resident of the Commonwealth of Massachusetts (the “Executive”).

American Renal Associates Holdings, Inc. – EMPLOYMENT AGREEMENT (October 14th, 2011)

This EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 13, 2011 (the “Effective Date”), among American Renal Management LLC, a Delaware limited liability company (the “Company”), American Renal Holdings Inc., a Delaware corporation (“ARH”), and Michael R. Costa, a resident of the Commonwealth of Massachusetts (the “Executive”).

American Renal Associates Holdings, Inc. – AMERICAN RENAL ASSOCIATES ANNOUNCES SECOND QUARTER 2011 RESULTS (August 11th, 2011)

Beverly, Massachusetts (August 11, 2011) – American Renal Associates Holdings, Inc., and its subsidiary American Renal Holdings, Inc. announced results today for the quarter ended June 30, 2011. Financial and operating highlights include:

American Renal Associates Holdings, Inc. – AMERICAN RENAL HOLDINGS COMPANY, INC., as Issuer 9.75%/10.50% Senior PIK Toggle Notes due 2016 INDENTURE Dated as of March 4, 2011 WILMINGTON TRUST FSB, as Trustee (July 22nd, 2011)

INDENTURE, dated as of March 4, 2011 (this “Indenture”), between AMERICAN RENAL HOLDINGS COMPANY, INC., a corporation duly organized and existing under the laws of the State of Delaware (the “Issuer”) and Wilmington Trust FSB, a federal savings bank, as trustee (the “Trustee”).

American Renal Associates Holdings, Inc. – 2011 AMERICAN RENAL ASSOCIATES HOLDINGS, INC. STOCK OPTION PLAN FOR NONEMPLOYEE DIRECTORS (July 22nd, 2011)
American Renal Associates Holdings, Inc. – REGISTRATION RIGHTS AGREEMENT by and between American Renal Holdings Company, Inc., and Merrill Lynch, Pierce, Fenner & Smith Incorporated Barclays Capital Inc. as Representatives of the several Initial Purchasers Dated as of March 4, 2011 (July 22nd, 2011)

This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 4, 2011, by and between American Renal Holdings Company, Inc., a Delaware corporation (the “Company”) and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Barclays Capital Inc., as Representatives of the several initial purchasers (collectively, the “Initial Purchasers” named on Schedule A to the Purchase Agreement), each of whom has agreed to purchase the Company’s 9.75% / 10.50% Senior PIK Toggle Notes due 2016 (the “Initial Notes”) pursuant to the Purchase Agreement (as defined below).